Home » Topics » BioWorld Science

BioWorld Science
RSS

Zeno Royalties & Milestones describes new Bcl-2 inhibitors

July 31, 2019

Almac Discovery synthesizes Wee1 inhibitors

July 31, 2019

Centaurus Therapeutics patents dihydroceramide desaturase inhibitors

July 31, 2019

Shuttle Pharmaceuticals presents HDAC6 inhibitors

July 31, 2019

Phase II study of ATI-501 in alopecia areata meets primary endpoint

July 31, 2019

Bexion completes end-of-phase I meeting with FDA for BXQ-350

July 31, 2019

Mezzion reports promising topline data from phase III FUEL study of udenafil

July 31, 2019

FDA approves Nubeqa for non-metastatic castration-resistant prostate cancer

July 31, 2019

Chipscreen Biosciences presents clinical data for chiglitazar in type 2 diabetes

July 31, 2019

Eisai reports death in phase I study of E-2082

July 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...